PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy
Michael Fraser1, Helen Zhao, Kaisa R Luoto
1Ontario Cancer Institute/Princess Margaret Hospital (University Health Network), University of Toronto, Toronto, Canada.
Purpose:
PTEN deletions in prostate cancer are associated with tumor aggression and poor outcome. Recent studies have implicated PTEN as a determinant of homologous recombination (HR) through defective RAD51 function. Similar to BRCA1/2-defective tumor cells, PTEN-null prostate and other cancer cells have been reported to be sensitive to PARP inhibitors (PARPi). To date, no direct comparison between PTEN and RAD51 expression in primary prostate tumors has been reported.
Experimental Design:
Prostate cancer cell lines and xenografts with known PTEN status (22RV1-PTEN(+/+), DU145-PTEN(+/-), PC3-PTEN(-/-)) and H1299 and HCT116 cancer cells were used to evaluate how PTEN loss affects RAD51 expression and PARPi sensitivity. Primary prostate cancers with known PTEN status were analyzed for RAD51 expression.
Results:
PTEN status is not associated with reduced RAD51 mRNA or protein expression in primary prostate cancers. Decreased PTEN expression did not reduce RAD51 expression or clonogenic survival following PARPi among prostate cancer cells that vary in TP53 and PTEN. PARPi sensitivity instead associated with a defect in MRE11 expression. PTEN-deficient cells had only mild PARPi sensitivity and no loss of HR or RAD51 recruitment. Clonogenic cell survival following a series of DNA damaging agents was variable: PTEN-deficient cells were sensitive to ionizing radiation, mitomycin-C, UV, H(2)O(2), and methyl methanesulfonate but not to cisplatin, camptothecin, or paclitaxel.
Conclusions:
These data suggest that the relationship between PTEN status and survival following DNA damage is indirect and complex. It is unlikely that PTEN status will be a direct biomarker for HR status or PARPi response in prostate cancer clinical trials.
Insights
PTEN loss in prostate cancer does not impact RAD51 expression or PARP inhibitor sensitivity. Instead, MRE11 defects correlate with PARPi sensitivity, suggesting PTEN status is not a reliable biomarker for HR status or PARPi response.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- PTEN deletions are linked to aggressive prostate cancer and poor outcomes.
- PTEN loss may affect homologous recombination (HR) via RAD51, potentially sensitizing tumors to PARP inhibitors (PARPi).
Purpose of the Study:
- To investigate the relationship between PTEN status, RAD51 expression, and PARPi sensitivity in prostate cancer.
- To determine if PTEN status can serve as a biomarker for HR deficiency and PARPi response.
Main Methods:
- Analyzed PTEN and RAD51 expression in prostate cancer cell lines, xenografts, and primary tumors.
- Assessed PARPi sensitivity and DNA damage response in PTEN-deficient cells.
- Correlated PTEN status with RAD51 expression and HR markers.
Main Results:
- PTEN status did not correlate with RAD51 mRNA or protein levels in primary prostate cancers.
- PTEN loss did not significantly reduce RAD51 expression or PARPi sensitivity.
- PARPi sensitivity was associated with MRE11 expression defects, not PTEN deficiency.
- PTEN-deficient cells showed variable sensitivity to DNA damaging agents, but not consistently to PARPi.
Conclusions:
- The link between PTEN status and DNA damage response is complex and indirect.
- PTEN status is unlikely to be a direct biomarker for HR status or PARPi response in prostate cancer clinical trials.
Related Concept Videos
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Line Loss
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Associative Learning
Classical conditioning, also known...
Energy Losses in Transformers
There are four main reasons for energy losses in transformers.
The first cause can be the high resistance of the...


